与雌激素相关的受体α:与年龄相关的黄斑退化症的潜在调节器
Fatima Massare Somers1, Goldis Malek2
1Department of Ophthalmology, Duke University School of Medicine, Durham, NC, USA.
Current opinion in pharmacology
|March 6, 2024
概括
与雌激素相关的受体α (ESRRA) 在与年龄相关的黄斑变性 (AMD) 病变发生过程中发挥着关键作用. 针对ESRRA信号可能为治疗这种致盲疾病提供了一种新的治疗策略.
科学领域:
- 眼科医生 眼科 眼科
- 分子生物学分子生物学
- 遗传学 遗传学 是一个
背景情况:
- 与年龄相关的黄斑变性 (AMD) 是导致视力丧失的主要原因.
- 了解AMD的潜在机制对于开发有效治疗方法至关重要.
- 与雌激素相关的受体α (ESRRA) 参与了几个与AMD相关的途径.
研究的目的:
- 审查ESRRA在老化和AMD期间在眼睛后极中的作用.
- 突出ESRRA作为AMD治疗的潜在分子标.
- 讨论针对ESRRA信号的治疗潜力.
主要方法:
- 对ESRRA和AMD研究的文献综述.
- 分析ESRRA在眼睛衰老和AMD病变发生过程中的作用.
- 对ESRRA信号通路向现有数据的评估.
主要成果:
- ESRRA调节了与AMD相关的多种致病途径.
- 在老化的眼睛后极和AMD中ESRRA在老化中的特定作用尚未得到充分研究.
- 有证据表明,ESRRA信号是一个可行的治疗目标.
结论:
- 在AMD病理生物学中,ESRRA是重要的分子标.
- 针对ESRRA代表了AMD的一个有希望的治疗途径.
- 对ESRRA信号的进一步研究对于AMD治疗开发是有必要的.
更多相关视频
06:18An In Vivo Estrogen Deficiency Mouse Model for Screening Exogenous Estrogen Treatments of Cardiovascular Dysfunction After Menopause
Published on: August 13, 2019
12.2K
09:24A Protocol to Evaluate and Quantify Retinal Pigmented Epithelium Pathologies in Mouse Models of Age-Related Macular Degeneration
Published on: March 10, 2023
1.6K
相关概念视频
The Effect of Aging on Tissues
Several body functions deteriorate with age. The external signs of aging are easily identifiable. For example, the skin becomes dry, less elastic, and thins out, forming wrinkles. The skin of the face begins to appear looser due to a decrease in the levels of elastic and collagen fibers in the connective tissue. Additionally, melanin production in the hair follicle decreases with age, resulting in gray hair. Moreover, the senses of sight and hearing decline, so glasses and hearing aids may...
Pharmacodynamics in Geriatric Patients: Effects of Age
Age-related pharmacokinetic changes are extensively documented, but understanding age-related pharmacodynamic alterations is relatively limited. This knowledge gap can be partly attributed to the complexity of developing appropriate measures of drug responses compared to bioanalytical methods for determining drug concentrations.Most information regarding age-related differences in human pharmacodynamics originates from cross-sectional studies. However, these studies assume that observed mean...
Pharmacogenetics of Drug Targets: β₂-Adrenergic Receptors, Apo E, Thymidylate Synthase
Genetic polymorphisms in drug targets have emerged as critical determinants of interindividual variability in drug response and toxicity. Pharmacogenomic investigations increasingly focus on identifying these variations to personalize and optimize therapeutic interventions. A drug target may be a receptor, enzyme, or signaling protein involved in pharmacologic responses or disease-related pathways. While early pharmacogenetic studies focused primarily on drug metabolism, current research...
